NRI 757

Subscribe to Selected New Research on NRI 757

4 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: an iodinated hepatocyte-specific lipid emulsion; a modified version of Intraiodol with cholesterol to amplify the hepatocyte uptake of lipid emulsion; composed of iodinated ethyl esters of fatty acids derived from poppy seed oil emulsified with egg yolk phospholipids & cholesterol

Also Known As:

FP 736-03; FP-736-03; NRI-757

Bio-Agent Context: Research Results

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 05/01/1997 - "PURPOSE: The aim of the study was to investigate whether moderately to well differentiated hepatocellular carcinomas (HCC) possess the same ability to take up a new lipid emulsion contrast medium, FP 736-03, as do hepatocytes. " Order ALL the reference details at left...
2.	Neoplasm Metastasis (Metastasis) 07/01/1998 - "PURPOSE: To evaluate the detection of experimental hepatic metastases at CT with the hepatocyte-specific contrast medium FP 736-03. " 07/01/1998 - "Detecting experimental liver metastases at CT with the hepatocyte-specific contrast medium FP 736-03." 11/01/1994 - "A hepatocyte-specific iodinated lipid emulsion, NRI 757, was used for detection of experimental hepatic metastases. " 01/01/1997 - "However, FP 736-03 proved superior to both native and iohexol-enhanced CT for detection of hepatic metastases. " Order ALL the reference details at left...
3.	Experimental Liver Neoplasms 05/01/1997 - "CT of experimental hepatoma using the hepatocyte-specific lipid emulsion FP 736-03." Order ALL the reference details at left...
4.	Body Weight (Weight, Body) 11/01/1994 - "A liver-to-lesion contrast of 45 Hounsfield units (HU) was obtained at a dose of 1 mL NRI 757/kg body weight (BW). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Iohexol (Omnipaque)

Best Treatments:
Research Summary Report
on Hepatocellular Carcinoma

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 850 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>